Literature DB >> 19863228

Quality assurance of volumetric modulated arc therapy using Elekta Synergy.

Akihiro Haga1, Keiichi Nakagawa, Kenshiro Shiraishi, Saori Itoh, Atsuro Terahara, Hideomi Yamashita, Kuni Ohtomo, Shigeki Saegusa, Toshikazu Imae, Kiyoshi Yoda, Roberto Pellegrini.   

Abstract

PURPOSE. Recently, Elekta has supplied volumetric modulated arc therapy (VMAT) in which multi-leaf collimator (MLC) shape, jaw position, collimator angle, and gantry speed vary continuously during gantry rotation. A quality assurance procedure for VMAT delivery is described. METHODS AND MATERIALS. A single-arc VMAT plan with 73 control points (CPs) and 5-degree gantry angle spacing for a prostate cancer patient has been created by ERGO + + treatment planning system (TPS), where MLC shapes are given by anatomic relationship between a target and organs at risk and the monitor unit for each CP is optimized based on given dose prescriptions. Actual leaf and jaw positions, gantry angles and dose rates during prostate VMAT delivery were recorded in every 0.25 seconds, and the errors between planned and actual values were evaluated. The dose re-calculation using these recorded data has been performed and compared with the original TPS plan using the gamma index. RESULTS. Typical peak errors of gantry angles, leaf positions, and jaw positions were 3 degrees, 0.6 mm, and 1 mm, respectively. The dose distribution obtained by the TPS plan and the recalculated one agreed well under 2%-2 mm gamma index criteria. CONCLUSIONS. Quality assurance for prostate VMAT delivery has been performed with a satisfied result.

Entities:  

Mesh:

Year:  2009        PMID: 19863228     DOI: 10.3109/02841860903081905

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  18 in total

1.  Toward a better understanding of the gamma index: Investigation of parameters with a surface-based distance method.

Authors:  Heng Li; Lei Dong; Lifei Zhang; James N Yang; Michael T Gillin; X Ronald Zhu
Journal:  Med Phys       Date:  2011-12       Impact factor: 4.071

2.  Quality assurance of dynamic parameters in volumetric modulated arc therapy.

Authors:  A Manikandan; B Sarkar; R Holla; T R Vivek; N Sujatha
Journal:  Br J Radiol       Date:  2012-07       Impact factor: 3.039

3.  Dose verification for respiratory-gated volumetric modulated arc therapy.

Authors:  Jianguo Qian; Lei Xing; Wu Liu; Gary Luxton
Journal:  Phys Med Biol       Date:  2011-07-13       Impact factor: 3.609

4.  Quality assurance of RapidArc in clinical practice using portal dosimetry.

Authors:  A Fogliata; A Clivio; P Fenoglietto; J Hrbacek; S Kloeck; P Lattuada; P Mancosu; G Nicolini; E Parietti; G Urso; E Vanetti; L Cozzi
Journal:  Br J Radiol       Date:  2011-06       Impact factor: 3.039

5.  Use of treatment log files in spot scanning proton therapy as part of patient-specific quality assurance.

Authors:  Heng Li; Narayan Sahoo; Falk Poenisch; Kazumichi Suzuki; Yupeng Li; Xiaoqiang Li; Xiaodong Zhang; Andrew K Lee; Michael T Gillin; X Ronald Zhu
Journal:  Med Phys       Date:  2013-02       Impact factor: 4.071

6.  Application of volumetric modulated arc therapy (VMAT) in a dual-vendor environment.

Authors:  Barbara Dobler; Karin Weidner; Oliver Koelbl
Journal:  Radiat Oncol       Date:  2010-10-25       Impact factor: 3.481

7.  Evaluation of volumetric modulated arc therapy (VMAT) with Oncentra MasterPlan® for the treatment of head and neck cancer.

Authors:  Judith Alvarez-Moret; Fabian Pohl; Oliver Koelbl; Barbara Dobler
Journal:  Radiat Oncol       Date:  2010-11-22       Impact factor: 3.481

8.  Dose verification of volumetric modulated arc therapy (VMAT) by use of in-treatment linac parameters.

Authors:  Akihiro Haga; Akira Sakumi; Yukari Okano; Saori Itoh; Naoya Saotome; Satoshi Kida; Hiroshi Igaki; Kenshiro Shiraishi; Hideomi Yamashita; Kuni Ohtomo; Keiichi Nakagawa
Journal:  Radiol Phys Technol       Date:  2013-03-12

9.  Evaluation of 4-Hz log files and secondary Monte Carlo dose calculation as patient-specific quality assurance for VMAT prostate plans.

Authors:  Philipp Szeverinski; Matthias Kowatsch; Thomas Künzler; Marco Meinschad; Patrick Clemens; Alexander F DeVries
Journal:  J Appl Clin Med Phys       Date:  2021-06-20       Impact factor: 2.102

10.  Anatomy-based volumetric modulated arc therapy for a prostate cancer patient with a hip prosthesis.

Authors:  Naoaki Kunishima; Yutaka Naoi; Kiyoshi Yoda
Journal:  J Radiat Res       Date:  2012-11-29       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.